Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07549958
Recruiting
PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC)
Phase 1 · United States · 1 site
Registry update: 4 May 2026
NCT07181941
Recruiting
Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma
Phase 1/2 · United States · 1 site
Registry update: 16 Sept 2026
NCT07078604
Recruiting
A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer
Phase 2 · United States · 1 site
Registry update: 4 Aug 2026
NCT07676565
Recruiting
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
Not applicable · United States · 17 sites
Registry update: 16 Oct 2026
NCT07526350
Recruiting
MTS109 in Patients With Refractory Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 30 Jun 2026
NCT07441382
Recruiting
Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
Not applicable · China · 1 site
Registry update: 8 Jun 2026
NCT07769528
Recruiting
Safety and Efficacy of the Extracorporeal Ventricular Assist System in Car Diogenic Shock: A Prospective, Multicenter , Single-Arm Study
Not applicable · China · 1 site
Registry update: 18 Aug 2026
NCT07763392
Recruiting
Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan
Not applicable · United States · 1 site
Registry update: 17 Aug 2026
NCT07405606
Recruiting
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Phase 2 · Canada · 1 site
Registry update: 26 Oct 2026
NCT07546097
Recruiting
Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）
Phase 4 · China · 4 sites
Registry update: 15 Jun 2026
NCT07275697
Recruiting
Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
Phase 4 · Sweden · 1 site
Registry update: 10 Aug 2026
NCT07176793
Recruiting
Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
Not applicable · United States · 1 site
Registry update: 14 Sept 2026
NCT07246330
Recruiting
Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study
Phase 3 · China · 1 site
Registry update: 23 Oct 2026
NCT06625762
Recruiting
Nantes Bariatric Surgery Cohort
Not applicable · France · 1 site
Registry update: 3 Apr 2026
NCT05991700
Recruiting
Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
Phase 1/2 · United States · 1 site
Registry update: 27 Apr 2026
NCT07351058
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Phase 3 · Argentina, Australia, Brazil, Canada, China, Czechia, Germany, Spain, France, United Kingdom, Hungary, Italy, Japan, South Korea, Mexico, Poland, Puerto Rico, Romania, Thailand, Taiwan, United States · 225 sites
Registry update: 13 Oct 2026
NCT07053982
Recruiting
Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions
Phase 2 · France · 1 site
Registry update: 25 Mar 2026
NCT07299019
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Phase 3 · Austria, Australia, Belgium, Bulgaria, Czechia, Germany, Denmark, Estonia, Spain, France, Georgia, Greece, Croatia, Hungary, Italy, Lithuania, Netherlands, Norway, Poland, Puerto Rico, Portugal, Romania, Serbia, Sweden, Slovenia, Slovakia, Ukraine, United States · 176 sites
Registry update: 4 Nov 2026
NCT07378969
Recruiting
A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therapy
Not applicable · Japan · 4 sites
Registry update: 6 Nov 2026
NCT07128680
Recruiting
Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
Phase 1 · United States · 2 sites
Registry update: 16 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.